GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (LSE:HVO) » Definitions » Moat Score

hVIVO (LSE:HVO) Moat Score : 0/10 (As of Jul. 22, 2025)


View and export this data going back to 2012. Start your Free Trial

What is hVIVO Moat Score?

hVIVO has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

hVIVO has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes hVIVO might have No Moat - No discernible moat.

hVIVO  (LSE:HVO) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

hVIVO Moat Score Related Terms

Thank you for viewing the detailed overview of hVIVO's Moat Score provided by GuruFocus.com. Please click on the following links to see related term pages.

hVIVO Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (LSE:HVO) » Definitions » Moat Score
Comparable Companies
LSE:OBI LSE:SCLP LSE:SBTX LSE:AVCT LSE:FUM LSE:POLB LSE:TRX LSE:SAR LSE:AREC LSE:OPTI VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX
Traded in Other Exchanges
ORPH:UK CRO:Germany
Address
40 Bank Street, Floor 24, London, GBR, E14 5NR
Website
https://www.hvivo.com
hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which is involved in the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.

hVIVO Headlines

No Headlines